The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)
Phase 1
Active, not recruiting
- Conditions
- Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN)
- Interventions
- First Posted Date
- 2024-10-24
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Renmin Hospital of Wuhan University
- Target Recruit Count
- 15
- Registration Number
- NCT06656962
- Locations
- 🇨🇳
Renmin hospital of Wuhan University, Wuhan, Hubei, China
The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy
Phase 2
Not yet recruiting
- Conditions
- Primary Membranous Nephropathy
- Interventions
- First Posted Date
- 2024-09-26
- Last Posted Date
- 2024-09-26
- Lead Sponsor
- Renmin Hospital of Wuhan University
- Target Recruit Count
- 172
- Registration Number
- NCT06614985
- Locations
- 🇨🇳
Renmin Hospital of Wuhan university, Wuhan, Hubei China, China
Metabolomic Profile of Vitreoretinal Diseases: an NMR-Based Approach Using Vitreous.
Recruiting
- Conditions
- Vitreoretinal Disease
- First Posted Date
- 2024-05-28
- Last Posted Date
- 2024-05-28
- Lead Sponsor
- Renmin Hospital of Wuhan University
- Target Recruit Count
- 450
- Registration Number
- NCT06429969
- Locations
- 🇨🇳
Eye, Center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
Artificial Intelligence-assisted System in Colonoscopy
Recruiting
- Conditions
- Adenoma Colon Polyp
- Interventions
- Device: ANDOANGEL
- First Posted Date
- 2024-05-09
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Renmin Hospital of Wuhan University
- Target Recruit Count
- 7500
- Registration Number
- NCT06406062
- Locations
- 🇨🇳
Renmin Hospital of Wuhan Univercity, Wuhan, Hubei, China
Young-onset Colorectal Cancer Screening Based on Artificial Intelligence
Completed
- Conditions
- Colorectal Cancer
- Interventions
- Diagnostic Test: Using routine clinical data and machine learning models.
- First Posted Date
- 2024-04-02
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- Renmin Hospital of Wuhan University
- Target Recruit Count
- 11000
- Registration Number
- NCT06342622
- Locations
- 🇨🇳
Renmin Hospital of Wuhan University, Wuhan, Hubei, China
First-line Apatinib Combined With Tislelizumab and Chemotherapy for Advanced GC
Phase 2
Completed
- Conditions
- Advanced Gastric Adenocarcinoma
- Interventions
- First Posted Date
- 2024-02-02
- Last Posted Date
- 2024-02-02
- Lead Sponsor
- Renmin Hospital of Wuhan University
- Target Recruit Count
- 33
- Registration Number
- NCT06238752
- Locations
- 🇨🇳
Renmin hosptial of Wuhan University, Wuhan, Hubei, China
Nutritional Psychological Intervention and Vomit-free Management on Survival and Quality of Life in Advanced Gastrointestinal Tumors
Not Applicable
Recruiting
- Conditions
- Digestive System CancerDigestive System Neoplasm
- Interventions
- Other: Nutritional psychological interventions and vomit-free management
- First Posted Date
- 2024-01-25
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Renmin Hospital of Wuhan University
- Target Recruit Count
- 316
- Registration Number
- NCT06223230
- Locations
- 🇨🇳
Renmin hosptial of Wuhan University, Wuhan, Hubei, China
A Study of the Tumor Microenvironment Affecting the Efficacy of Immunotherapy for Esophageal Cancer
Completed
- Conditions
- Esophageal Cancer
- Interventions
- Other: no intervention
- First Posted Date
- 2024-01-23
- Last Posted Date
- 2024-01-26
- Lead Sponsor
- Renmin Hospital of Wuhan University
- Target Recruit Count
- 22
- Registration Number
- NCT06219031
- Locations
- 🇨🇳
Renmin hosptial of Wuhan University, Wuhan, Hubei, China
Wuhan High Myopia Study
Recruiting
- Conditions
- High Myopia
- Interventions
- Other: observational
- First Posted Date
- 2023-12-08
- Last Posted Date
- 2023-12-27
- Lead Sponsor
- Renmin Hospital of Wuhan University
- Target Recruit Count
- 1000
- Registration Number
- NCT06162234
- Locations
- 🇨🇳
Renmin Hospital of Wuhan University, Wuhan, Hubei, China
Effect of the Automatic Surveillance System on Surveillance Rate of Patients with Gastric Premalignant Lesions
Not Applicable
Recruiting
- Conditions
- SurveillanceArtificial Intelligence
- Interventions
- Other: AI based automatic surveillance (AS) system (ENDOANGEL-AS)Other: Manually remind the patients
- First Posted Date
- 2023-09-15
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Renmin Hospital of Wuhan University
- Target Recruit Count
- 1460
- Registration Number
- NCT06039917
- Locations
- 🇨🇳
Jinjiang Municipal Hospital, Shanghai Sixth People's Hospital Fujian Campus, Quanzhou, Fujian, China
🇨🇳The Eighth Hospital of Wuhan, Wuhan, Hubei, China
🇨🇳Renmin Hospital of Wuhan University, Wuhan, Hubei, China
© Copyright 2025. All Rights Reserved by MedPath